| PCa | prostate cancer |
| AR | androgen receptor |
| ARS | AR-signaling |
| NGS | next-generation sequencing |
| DDR | DNA damage repair |
| mCRPC | metastatic castration-resistant PCa |
| CSS | cause-specific survival |
| PARP | poly (adenosine diphosphate [ADP]-ribose) polymerase |
| PD | programmed death |
| PSA | prostate-specific antigen |
| ICI | immune checkpoint inhibitors |
| SSB | single-stranded breaks |
| DSB | double-stranded breaks |
| HR | homologous recombination |
| NHEJ | non-homologous end joining |
| MMR | mismatch repair |
| PSMA | prostate-specific membrane antigen |
| CAR-T | chimeric antigen receptor-T |